Horizontal integration between brand and generic firms in the pharmaceutical industry

Journal of Economics and Management Strategy

Volumn 11, Issue 1, 2002, Pages 135-168

  Scott Morton, Fiona M ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0036523203     PISSN: 10586407     EISSN: None     Source Type: Journal    
DOI: 10.1162/105864002317247604     Document Type: Article

References (16)

1. Bradley, M., A. Desai, and E.H. Kim, 1988. "Synergistic Gains from Corporate Acquisitions and Their Division between the Stockholders of Target and Acquiring Firms," Journal of Financial Economics, 21 (1), 3-40.
2. Cockburn, I. and R. Henderson, 1996, "Scale, Scope, and Spillovers," The RAND Journal of Economics, 27, 1.
3. DiMasi, J., R. Hansen, H. Grabowski, and L. Lasagna, 1991, "Cost of Innovation in the Pharmaceutical Industry," Journal of Health Economics, 10 (2), 107-142.
4. Frank, R. and D. Salkever, 1997, "Generic Entry and the Pricing of Pharmaceuticals," Journal of Economics and Management Strategy, 6 (1), 75-90.
5. Jensen, M., 1989, "The Eclipse of the Public Corporation," Harvard Business Review.
6. Milgrom, P. and D.J. Roberts, 1990, "The Economics of Modern Manufacturing: Technology, Strategy, and Organization," American Economic Review, 80 (3), 511-528.
7. Murdock, K., 1998, "Intrinsic Motivation and Optimal Incentive Contracts," Stanford GSB Working Paper 1506.
8. Myers, S. and N. Majluf, 1984, "Corporate Financing and Investment Decisions When Firms Have Information That Investors Do Not Have," Journal of Financial Economics, 13 (2), 187-221.
9. Olson, M., 1997, "Firm Characteristics and the Speed of FDA Approval," Journal of Economics and Management Strategy, 6 (2), 377-401.
10. Scott Morton, F. 1994, "The Objectives of the FDA's Office of Generic Drugs," NBER Working Paper 6143.
11. _, 1999, "Entry Decisions in the Generic Pharmaceutical Industry," The RAND Journal of Economics, 30 (3), 421-440.
12. _, 2000, "Barriers to Entry, Brand Advertising, and Generic Entry in the U.S. Pharmaceutical Industry," International Journal of Industrial Organization, 18 (7), 1085-1104.
13. Stern, S., 1999, "Do Scientists Pay to Be Scientists? Evidence from R & D Job Offers," Draft, MIT Sloan School.
14. Thwaite, E. 1996, "Generics: Potent Medicine," Chemical Week, April 10, p. 33.
15. -, 1998, "Brand Name and Generic Companies Jockey for Off-Patent Business Position," Medical Marketing and Media, 33 (5), 74-82.
16. Wiggins, S. and R. Maness, 1995, "Price Competition in Pharmaceuticals: The Case of Antiinfectives," Draft, Texas A & M.